Literature DB >> 25755788

Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.

Ming-Wei Zhu1, Jia Liu2, Thomas Arzberger3, Lu-Ning Wang1, Zhen-Fu Wang1.   

Abstract

Progressive supranuclear palsy (PSP) is an atypical parkinsonism, which is the third most common geriatric neurodegenerative disease. We reported three pathology-confirmed Chinese PSP cases with special focus on the pathological accumulations of tau, a-synuclein and A-beta in the three PSP brains. Cases 1 and 2 initiated with extrapyramidal signs and gait disorders, while case 3 suffered behavioral abnormalities with cognitive decline at the beginning. In neuropathology, PSP-changes such as tau-positive tufed astrocytes, oligdendrocytes with the tau-positive coiled-body and threads and globose NFTs were widely seen in the basal ganglia, isocortex and allocortex, as well as in brainstem, cerebellum and spinal cord. In addition, numerous AGs were found in the hippocampus of cases 1 & 2, while Aβ amyloid depositions were found in hippocampus and leptomeningeal vessels of case 1 and in neocortex, entorhinal cortex, hippocampus, cingulate gyrus and amygdale of case 3. Vessel infarcts were observed in cases 1. Cortical laminar III necrosis in case 1 suggested the ischemic damage. Cervical spinal cords in cases 2 & 3 were obtained with tau-positive globose NFTs, tufted astrocytes and neuropil threads were respectively found in the neurons of anterior horn and surrounding white matters. In summary, pathological examination is crucial for the ambiguous cases to exclude other neurodegenerative diseases. Furthermore, cervical spinal cord should be routinely examined in the PSP autopsy.

Entities:  

Keywords:  Alzheimer’s disease; Progressive supranuclear palsy; autopsy; pathology

Mesh:

Year:  2015        PMID: 25755788      PMCID: PMC4348809     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Teaching NeuroImages: "Penguin" or "hummingbird" sign and midbrain atrophy in progressive supranuclear palsy.

Authors:  Jerome J Graber; Robert Staudinger
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

3.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

Authors:  K A Josephs; B F Boeve; J R Duffy; G E Smith; D S Knopman; J E Parisi; R C Petersen; D W Dickson
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

4.  Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Demetrio Messina; Antonio Cerasa; Francesca Condino; Gennarina Arabia; Fabiana Novellino; Giuseppe Nicoletti; Maria Salsone; Maurizio Morelli; Pier Luigi Lanza; Aldo Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2011-01-13       Impact factor: 4.891

5.  Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.

Authors:  Y Tsuboi; J E Ahlskog; H Apaydin; J E Parisi; D W Dickson
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

Review 6.  Argyrophilic grain disease.

Authors:  Isidro Ferrer; Gabriel Santpere; Fred W van Leeuwen
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

7.  Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.

Authors:  Masato Kanazawa; Mari Tada; Osamu Onodera; Hitoshi Takahashi; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  Parkinsonism Relat Disord       Date:  2013-08-03       Impact factor: 4.891

8.  Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.

Authors:  Kenichi Oshima; Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2008-12-20

9.  Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.

Authors:  Osamu Yokota; Yvonne Davidson; Eileen H Bigio; Hideki Ishizu; Seishi Terada; Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Stephen Sikkink; Stuart Pickering-Brown; David M A Mann
Journal:  Acta Neuropathol       Date:  2010-05-30       Impact factor: 17.088

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.